ISNR completes $200M SPAC IPO; discloses material weakness in internal controls

Filed July 17, 2026 · Period ending March 31, 2026 · ~2 min read

Key Changes

• high

  Management concluded disclosure controls ineffective as of March 31, 2026 due to material weakness: inadequate segregation of duties from limited personnel and insufficient written policies across accounting, IT, and financial reporting. Remediation underway via third-party support, but no assurance of success.

  Controls & Procedures verify on EDGAR →
• high

  Company has until June 10, 2028 (extendable to September 10, 2028 with signed agreement) to complete a business combination, or will liquidate and return trust proceeds to public shareholders. Nasdaq delisting occurs if no combination by June 8, 2029 under 36-Month SPAC Rule.

  MD&A: Business Combination Deadline verify on EDGAR →
• high

  Deferred underwriting and advisory fees total $13.56M ($6.78M to underwriters, $6.78M to Santander), payable only upon closing a business combination. These fees reduce net proceeds available from the $226M trust account for acquisition and post-combination working capital.

  MD&A: Deferred Fees verify on EDGAR →